Metabolomic fingerprint of severe obesity is dynamically affected by bariatric surgery in a procedure-dependent manner
Ewa Gralka, Claudio Luchinat, Leonardo Tenori, Barbara Ernst, Martin Thurnheer, Bernd Schultes, Ewa Gralka, Claudio Luchinat, Leonardo Tenori, Barbara Ernst, Martin Thurnheer, Bernd Schultes
Abstract
Background: Obesity is associated with multiple diseases. Bariatric surgery is the most effective therapy for severe obesity that can reduce body weight and obesity-associated morbidity. The metabolic alterations associated with obesity and respective changes after bariatric surgery are incompletely understood.
Objective: We comprehensively assessed metabolic alterations associated with severe obesity and distinct bariatric procedures.
Design: In our longitudinal observational study, we applied a (1)H-nuclear magnetic resonance-based global, untargeted metabolomics strategy on human serum samples that were collected before and repeatedly ≤1 y after distinct bariatric procedures [i.e., a sleeve gastrectomy, proximal Roux-en Y gastric bypass (RYGB), and distal RYGB]. For comparison, we also analyzed serum samples from normal-weight and less-obese subjects who were matched for 1-y postoperative body mass index (BMI) values of the surgical groups.
Results: We identified a metabolomic fingerprint in obese subjects that was clearly discriminated from that of normal-weight subjects. Furthermore, we showed that bariatric surgery (sleeve gastrectomy and proximal and distal RYGB) dynamically affected this fingerprint in a procedure-dependent manner, thereby establishing new fingerprints that could be discriminated from those of BMI-matched and normal-weight control subjects. Metabolites that largely contributed to the metabolomic fingerprints of severe obesity were aromatic and branched-chain amino acids (elevated), metabolites related to energy metabolism (pyruvate and citrate; elevated), and metabolites suggested to be derived from gut microbiota (formate, methanol, and isopropanol; all elevated).
Conclusion: Our data indicate that bariatric surgery, irrespective of the specific kind of procedure used, reverses most of the metabolic alterations associated with obesity and suggest profound changes in gut microbiome-host interactions after the surgery. This trial was registered at clinicaltrials.gov as NCT02480322.
Keywords: NMR spectroscopy; Roux-en Y gastric bypass; metabolomics; metabonomics; sleeve gastrectomy.
© 2015 American Society for Nutrition.
Source: PubMed